Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed PatientsDaniel Podzamczer, Montserrat Olmo, Jose Sanz, et al.
Immunity|August 20, 2020
Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the IntestineShiyan Yu, Iyshwarya Balasubramanian, Daniel Laubitz, et al.
British Journal of Haematology|December 9, 2021
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow studyMartijn W C Verbeek, Chiara Buracchi, Anna Laqua, et al.
Blood Cancer Journal|December 1, 2023
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality indexJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal|October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaAlejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 28, 2014
Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance roundsTomas Kalina, Juan Flores-Montero, Quentin Lecrevisse, et al.
Blood|March 14, 2008
Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patientsSandra Quijano, Antonio López, Ana Rasillo, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2025
Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell TransplantationBorja Puertas, Elena Alejo, José J Pérez-Morán, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple MyelomaMarta Lasa, Laura Notarfranchi, Cristina Agullo, et al.
British Journal of Haematology|June 18, 2026
Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survivalBorja Puertas, Irene Padilla, Elena Alejo, et al.
Pageof 14